Concepedia

Author

M. Brian Arnold

Eli Lilly (United States)

Also Known As

Arnold, Marco, M. B. ARNOLD, M. Brian Arnold, M.B. Arnold, M.Brian Arnold, Macklin B. Arnold, Marco Arnold

37

Publications

1.3K

Citations

20

H-Index

30

Concepts

All Affiliations

Eli Lilly (United States)
MB

About

M. Brian Arnold is an author at Eli Lilly (United States) specializing in pharmacology, medicine, and biochemistry.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

15

15

771

2

Biochemistry

15

16

791

3

Natural Sciences

13

13

607

4

Engineering

1

1

29

5

Biomolecular Engineering

1

1

42

M. Brian Arnold

×

23

Publications

1.3K

Citations

20

H-Index

YearCitations

Synthesis and Evaluation of a Series of Novel 2-[(4-Chlorophenoxy)methyl]- benzimidazoles as Selective Neuropeptide Y Y1 Receptor Antagonists

Hamideh Zarrinmayeh, Anne M. Nunes, Paul L. Ornstein,

Journal of Medicinal Chemistry

1998

152

(3SR,4aRS,6RS,8aRS)-6-[2-(1H-Tetrazol-5-yl)ethyl]decahydroisoquinoline-3-carboxylic acid: a structurally novel, systemically active, competitive AMPA receptor antagonist

Paul L. Ornstein, M. Brian Arnold, Nancy K. Augenstein,

Journal of Medicinal Chemistry

1993

123

2-Substituted (2<i>SR</i>)-2-Amino-2-((1<i>SR</i>,2<i>SR</i>)-2-carboxycycloprop-1-yl)glycines as Potent and Selective Antagonists of Group II Metabotropic Glutamate Receptors. 2. Effects of Aromatic Substitution, Pharmacological Characterization, and Bioavailability

Paul L. Ornstein, Thomas J. Bleisch, M. Brian Arnold,

Journal of Medicinal Chemistry

1998

100

[3H]-LY341495 as a novel antagonist radioligand for group II metabotropic glutamate (mGlu) receptors: characterization of binding to membranes of mGlu receptor subtype expressing cells

Bryan G. Johnson, Rebecca A. Wright, M. Brian Arnold,

Neuropharmacology

1999

100

[3H]LY341495 Binding to Group II Metabotropic Glutamate Receptors in Rat Brain

Rebecca A. Wright, M. Brian Arnold, William J. Wheeler,

Journal of Pharmacology and Experimental Therapeutics

2001

99

4-(Tetrazolylalkyl)piperidine-2-carboxylic acids. Potent and selective N-methyl-D-aspartic acid receptor antagonists with a short duration of action

Paul L. Ornstein, D D Schoepp, M. Brian Arnold,

Journal of Medicinal Chemistry

1991

85

Biarylpropylsulfonamides as Novel, Potent Potentiators of 2-Amino-3- (5-methyl-3-hydroxyisoxazol-4-yl)- propanoic Acid (AMPA) Receptors

Paul L. Ornstein, Dennis M. Zimmerman, M. Brian Arnold,

Journal of Medicinal Chemistry

2000

75

2-Substituted (2<i>SR</i>)-2-Amino-2-((1<i>SR</i>,2<i>SR</i>)-2-carboxycycloprop-1-yl)glycines as Potent and Selective Antagonists of Group II Metabotropic Glutamate Receptors. 1. Effects of Alkyl, Arylalkyl, and Diarylalkyl Substitution

Paul L. Ornstein, Thomas J. Bleisch, M. Brian Arnold,

Journal of Medicinal Chemistry

1998

72

Binding of [ 3 H](2 S ,1' S ,2' S )-2-(9-xanthylmethyl)-2-(2'-carboxycyclopropyl)glycine ([ 3 H]LY341495) to cell membranes expressing recombinant human group III metabotropic glutamate receptor subtypes

Rebecca A. Wright, M. Brian Arnold, William J. Wheeler,

Naunyn-Schmiedeberg s Archives of Pharmacology

2000

63

Structure−Activity Studies of 6-(Tetrazolylalkyl)-Substituted Decahydroisoquinoline-3-carboxylic Acid AMPA Receptor Antagonists. 1. Effects of Stereochemistry, Chain Length, and Chain Substitution

Paul L. Ornstein, M. Brian Arnold, Nancy K. Allen,

Journal of Medicinal Chemistry

1996

47

Page 1